by admin | Jun 2, 2025 | Uncategorized
Tecrea Ltd. is proud to announce the successful completion of the Scaling Out for Impact (SOFI 2) program, in collaboration with a South African-based company. The SOFI2 program aims to accelerate the development and deployment of affordable, accessible innovative...
by admin | Nov 22, 2024 | Uncategorized
Tecrea Ltd is proud to announce its selection for the latest cohort of the Accelerating FemTech programme, funded by Innovate UK and the Medical Research Council, and delivered by the Health Innovation Network (HIN) South London in collaboration with partners across...
by admin | Nov 11, 2024 | Uncategorized
Tecrea Ltd. is working alongside a South African-based company as part of the Scaling Out for Impact (SOFI 2) program, aimed at advancing UK-South Africa innovation partnerships. This program seeks to accelerate the development and implementation of affordable,...
by admin | Jul 8, 2024 | Uncategorized
Tecrea Ltd. has received Innovate UK funding in collaboration with a global veterinary pharmaceutical company to develop a novel therapy for dairy cows that combines tissue release and infection control.Through support from Innovate UK the project will focus on...
by admin | Apr 16, 2024 | Uncategorized
A recent Phase 2b human clinical study involving Tecrea’s Nanocin technology as part of a novel topical terbinafine antifungal product, has met the primary endpoint (BBTAF202) in patients with onychomycosis, showing superiority over placebo (vehicle) with a high...
